Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?
Didanosine (ddI) associates with increased liver fibrosis in adult HIV–HCV coinfected patients
Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study
Interobserver discrepancy in liver fibrosis using transient elastography
Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro
Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis
Large hepatitis delta antigen activates STAT-3 and NF-κB via oxidative stress
Specific primer sets used to amplify by PCR the hepatitis B virus overlapping S/Pol region select different viral variants